Jacobi Capital Management’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Jacobi Capital Management’s Portfolio FXH Stock Details FXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$880K	Buy	7,192 +5	+0.1%	+$573	0.04%	353
2026 Q1	$789K	Buy	7,187 +10	+0.1%	+$1.13K	0.04%	331
2025 Q4	$817K	Buy	7,177 +8	+0.1%	+$907	0.05%	314
2025 Q3	$786K	Buy	7,169 +81	+1%	+$8.49K	0.05%	309
2025 Q2	$735K	Buy	7,088 +3	+0%	+$301	0.05%	306
2025 Q1	$734K	Buy	7,085 +109	+2%	+$11.7K	0.05%	296
2024 Q4	$726K	Buy	6,976 +5	+0.1%	+$543	0.05%	292
2024 Q3	$780K	Buy	6,971 +6	+0.1%	+$657	0.06%	291
2024 Q2	$728K	Sell	6,965 -103	-1%	-$10.8K	0.06%	266
2024 Q1	$775K	Buy	7,068 +13	+0.2%	+$1.37K	0.07%	244
2023 Q4	$731K	Sell	7,055 -124	-2%	-$11.9K	0.07%	234
2023 Q3	$698K	Buy	7,179 +27	+0.4%	+$2.8K	0.08%	226
2023 Q2	$775K	Sell	7,152 -148	-2%	-$15.8K	0.09%	213
2023 Q1	$785K	Buy	7,300 +3	+0%	+$326	0.09%	204
2022 Q4	$793K	Buy	7,297 +28	+0.4%	+$2.94K	0.1%	206
2022 Q3	$707K	Sell	7,269 -59	-0.8%	-$6.21K	0.1%	203
2022 Q2	$756K	Buy	7,328 +83	+1%	+$8.94K	0.1%	195
2022 Q1	$831K	Hold	7,245	–	–	0.1%	191
2021 Q4	$900K	Sell	7,245 -95	-1%	-$11.4K	0.11%	179
2021 Q3	$874K	Hold	7,340	–	–	0.11%	158
2021 Q2	$860K	Hold	7,340	–	–	0.11%	163
2021 Q1	$797K	Hold	7,340	–	–	0.12%	163
2020 Q4	$791K	Hold	7,340	–	–	0.12%	144
2020 Q3	$695K	Hold	7,340	–	–	0.12%	143
2020 Q2	$662K	Buy	7,340 +78	+1%	+$6.69K	0.12%	138
2020 Q1	$537K	Sell	7,262 -356	-5%	-$28.9K	0.12%	142
2019 Q4	$641K	Buy	7,618 +5,493	+258%	+$435K	0.12%	156
2019 Q3	$157K	Hold	2,125	–	–	0.03%	299
2019 Q2	$165K	Hold	2,125	–	–	0.03%	292
2019 Q1	$162K	Buy	2,125 +350	+20%	+$26.1K	0.04%	254
2018 Q4	$122K	Hold	1,775	–	–	0.03%	275
2018 Q3	$151K	Hold	1,775	–	–	0.04%	269
2018 Q2	$132K	Hold	1,775	–	–	0.04%	268
2018 Q1	$120K	Hold	1,775	–	–	0.04%	268
2017 Q4	$127K	Sell	1,775 -52	-3%	-$3.55K	0.04%	224
2017 Q3	$123K	Hold	1,827	–	–	0.04%	211
2017 Q2	$122K	Buy	1,827 +759	+71%	+$48.8K	0.05%	176
2017 Q1	$66K	Hold	1,068	–	–	0.03%	206
2016 Q4	$63K	Buy	+1,068	New	+$61.9K	0.04%	194

Other funds holding FXH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PWP

Prasad Wealth Partners Independence, Ohio $416M AUM 21.9% 1-Year Est. Return

PFA

Perryman Financial Advisory Dallas, Texas $751M AUM

Jacobi Capital Management's FXH Position: Q2 2026 in Review

Jacobi Capital Management increased its First Trust Health Care AlphaDEX Fund (FXH) stake by 0.07% in Q2 2026, buying an estimated $573 and bringing the position to 7,192 shares worth $880K. The position accounts for 0.04% of the portfolio, ranked #353.

Jacobi Capital Management first reported a position in FXH in Q4 2016 and has held it in 39 quarters since. The position peaked at $900K in Q4 2021. 252 funds tracked by Wall St. Rank hold FXH as of Q2 2026.

Jacobi Capital Management held 7,192 shares of First Trust Health Care AlphaDEX Fund worth $880K as of Q2 2026.
Jacobi Capital Management bought 5 First Trust Health Care AlphaDEX Fund shares in Q2 2026, an estimated $573.
First Trust Health Care AlphaDEX Fund made up 0.04% of Jacobi Capital Management's portfolio in Q2 2026, its #353 holding.
Jacobi Capital Management first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2016 and has held it in 39 quarters since.
Jacobi Capital Management's First Trust Health Care AlphaDEX Fund position peaked at $900K in Q4 2021.
252 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q2 2026.

Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.